Updated Results and Correlative Analysis: Autologous CD30.CAR-T-Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial)
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:7496-7497 - Subject
- Language
- ISSN
- 0006-4971